BioWorld

May 16, 1996

View Archived Issues

HYBRIDON'S ANTISENSE STRIKES OUT KEY MOLECULE CAUSING BLINDNESS OF

Read More

RHONE-POULENC RORER'S TAXOTERE GETS FDA MARKET APPROVAL

Read More

OTHER NEWS TO NOTE

Read More

EUROPEAN PATENT DISCLOSURES

Read More

UMASS SIGNS $42M DEAL FOR DNA-BASED VACCINES

Read More

SECOND GENETICS INSTITUTE PHASE II TRIAL POSITIVE FOR PLATELET GROWTH

Read More

MICROCIDE IPO GENERATES $35M, JUMPS 30 PERCENT OPENING DAY

Read More

ALKERMES COMPLETES $23M FINANCING IN LESS THAN A WEEK

Read More